Firm
Ladenburg Thalmann
MST Access
Analyst
Aydin Huseynov, M.D., CFA
Rosemary Cummins
Alterity Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Alterity Therapeutics’ performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Alterity Therapeutics or its management. Alterity Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.